{
  "id": 1433,
  "text": "A second identified meta-analysis1381 (eighteen $\\operatorname { R C T } s ^ { 6 7 , 7 2 1 , 1 1 2 9 , 1 2 6 9 , 1 3 8 2 - 1 3 9 5 } )$ comparing the effectiveness and safety of chemoradiotherapy with radiotherapy alone in LACC reported significant differences in terms of response rate, 3-year OS rates, and 5-year OS rates in favour of patients in the chemoradiotherapy group ( $\\mathrm { R R } = 1 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: A second identified meta-analysis1381 (eighteen $\\operatorname { R C T } s ^ { 6 7 , 7 2 1 , 1 1 2 9 , 1 2 6 9 , 1 3 8 2 - 1 3 9 5 } )$ comparing the effectiveness and safety of chemoradiotherapy with radiotherapy alone in LACC reported significant differences in terms of response rate, 3-year OS rates, and 5-year OS rates in favour of patients in the chemoradiotherapy group ( $\\mathrm { R R } = 1\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在局部晚期宫颈癌（LACC）的治疗中，比较同步放化疗与单纯放疗时，同步放化疗在缓解率、三年总生存率及五年总生存率方面表现出显著的优势。缓解率上，同步放化疗组患者的表现优于单纯放疗组。在生存率方面，同步放化疗提高了三年和五年的总生存率，这表明这种治疗方法可能更有效地延长患者的生命。同时，虽然同步放化疗在某些方面可能会增加治疗副作用的风险，但总体而言其效果趋于使患者受益。",
  "query": "**在局部晚期宫颈癌 (LACC) 的治疗中，比较同步放化疗与单纯放疗的效果和安全性时，两种治疗方法在缓解率、三年总生存率及五年总生存率方面有什么显著差异？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **在局部晚期宫颈癌 (LACC) 的治疗中，比较同步放化疗与单纯放疗的效果和安全性时，两种治疗方法在缓解率、三年总生存率及五年总生存率方面有什么显著差异？**\n\n<reference text>: A second identified meta-analysis1381 (eighteen $\\operatorname { R C T } s ^ { 6 7 , 7 2 1 , 1 1 2 9 , 1 2 6 9 , 1 3 8 2 - 1 3 9 5 } )$ comparing the effectiveness and safety of chemoradiotherapy with radiotherapy alone in LACC reported significant differences in terms of response rate, 3-year OS rates, and 5-year OS rates in favour of patients in the chemoradiotherapy group ( $\\mathrm { R R } = 1 .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在局部晚期宫颈癌（LACC）的治疗中，比较同步放化疗与单纯放疗时，同步放化疗在缓解率、三年总生存率及五年总生存率方面表现出显著的优势。缓解率上，同步放化疗组患者的表现优于单纯放疗组。在生存率方面，同步放化疗提高了三年和五年的总生存率，这表明这种治疗方法可能更有效地延长患者的生命。同时，虽然同步放化疗在某些方面可能会增加治疗副作用的风险，但总体而言其效果趋于使患者受益。"
}